About
Philip Chase is the current CEO of Adimab. He previously worked at Alnylam Pharmaceuticals as a General Counsel. Philip Chase attended Columbia Law School.
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Philip Chase is one of them.
- • 24 investors are based in Needham, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Needham, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Philip
Search Investors